V30.F Apotea AB (publ)

Healthcare Pharmaceutical Retailers Frankfurt Exchange
9.24 EUR
Close of Nov 12, 2026
5.01 9.66
Market cap
EUR 962M
P/E
38.2x
P/B
10.64x
ROE
31.4%
Dividend yield
0.58%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is V30.F undervalued?

Graham number

The Graham number of Apotea AB (publ) cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Apotea AB (publ) fundamental analysis

No fundamental analysis for Apotea AB (publ) yet.

Apotea AB (publ) stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Apotea AB (publ)

Apotea AB (publ) operates an online pharmacy in Sweden. The company offers products in the areas of allergy, face, baby, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, and dietary supplements. It also provides products in the categories of body care, stomach and intestine, food and drink, mouth and teeth, premium, trip, sex and lust, stop smoking, makeup, s…

Full company profile